{
    "eid": "2-s2.0-84904738766",
    "title": "A prospective analytical study of the effects and adverse events of alendronate (Aldren70\u00ae) treatment in Thai postmenopausal women",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [
        "Alendronate",
        "BMD",
        "Bone markers",
        "Menopause",
        "Osteoporosis"
    ],
    "authors": [
        "Prakit Tienboon"
    ],
    "citedby-count": 2,
    "ref-count": 31,
    "ref-list": [
        "Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models",
        "Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women",
        "Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis",
        "The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis",
        "Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: A randomized, double-blind, placebo-controlled trial",
        "Skeletal benefits of alendronate: 7-Year treatment of postmenopausal osteoporotic women",
        "Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities: A randomized, double-blind, placebo-controlled trial",
        "Fracture risk reduction with alendronate in women with osteoporosis: The fractureintervention trial",
        "Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density",
        "Endocr Pract",
        "Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women",
        "Alendronate in the prevention of osteoporosis: 7-year follow-up",
        "Alendronate in the treatment of osteoporosis: A Review of the clinical trials",
        "Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX trial",
        "Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation",
        "Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV",
        "Effect of alendronate on bone mineral density and bone turnover markers in post-gastrectomy osteoporotic patients",
        "Alendronate prevents bone loss in patients with acute spinal cord injury: A randomized, double-blind, placebo-controlled study",
        "Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease",
        "Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: A 3-year randomized placebo-controlled trial",
        "Alendronate and atrial fibrillation: A meta-analysis of randomized placebo-controlled clinical trials",
        "Gastric ulcerogenic and healing impairment actions of Alendronate, a Nitrogen- containing bisphosphonate - prophylactic effects of Rebamipide",
        "The comparative gastrointestinal tolerability of proprietary versus generic alendronate in patients treated for primary osteoporosis",
        "Diffuse skeletal pain after administration of alendronate",
        "Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: An open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers",
        "Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment",
        "Long-term risk of osteoporotic fracture in Malmo",
        "Measurement of osteocalcin",
        "Levels of biochemical bone marker Procollagen type I N-propeptide (PINP) in Thai women aged 40-70 years",
        "Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy",
        "Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}